Evidence map›Paper›PMID 32814583›Full record

SynthesisWorld journal of surgical oncology2020

Meta-analysis of laparoscopic anterior resection with natural orifice specimen extraction (NOSE-LAR) versus abdominal incision specimen extraction (AISE-LAR) for sigmoid or rectal tumors.

Jun He, Hai-Bo Yao, Chang-Jian Wang, Qin-Yan Yang, Jian-Ming Qiu, Jin-Ming Chen, Zhong Shen, Guan-Gen Yang

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in World journal of surgical oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 4 pooled it
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 4 syntheses or guidelines pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Outcomes after natural orifice extractionWorld journal of clinical oncology · 2022
    Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jun HeDepartment of Colorectal Surgery, Hangzhou Third Hospital, Hangzhou, 310009, Zhejiang, People's Republic of China.
Hai-Bo YaoDepartments of Gastroenterology & Pancreatic Surgery, Zhejiang Provincial People's Hospital, Hangzhou, 310014, Zhejiang, People's Republic of China.
Chang-Jian WangDepartment of Colorectal Surgery, Hangzhou Third Hospital, Hangzhou, 310009, Zhejiang, People's Republic of China.
Qin-Yan YangDepartment of Colorectal Surgery, Hangzhou Third Hospital, Hangzhou, 310009, Zhejiang, People's Republic of China.
Jian-Ming QiuDepartment of Colorectal Surgery, Hangzhou Third Hospital, Hangzhou, 310009, Zhejiang, People's Republic of China.
Jin-Ming ChenDepartment of Colorectal Surgery, Hangzhou Third Hospital, Hangzhou, 310009, Zhejiang, People's Republic of China.
Zhong ShenDepartment of Colorectal Surgery, Hangzhou Third Hospital, Hangzhou, 310009, Zhejiang, People's Republic of China.
Guan-Gen YangDepartment of Colorectal Surgery, Hangzhou Third Hospital, Hangzhou, 310009, Zhejiang, People's Republic of China. guangenyang@163.com.ORCID http://orcid.org/0000-0002-2548-1715
Third People's Hospital of Hangzhou · CNZhejiang Provincial People's Hospital · CN

Funding

Hangzhou Health Science and Technology Project 2017A26Zhejiang Medical Health Science and Technology Project 2019323421Zhejiang Natural Science Foundation LQ19H160013
6 · The paper itself

Abstract

backgroundNatural orifice specimen extraction surgery is a novel technique of minimally invasive surgery. The purpose of this study was to compare the safety of laparoscopic anterior resection with natural orifice specimen extraction (NOSE-LAR) and abdominal incision specimen extraction (AISE-LAR) for sigmoid or rectum tumors.

methodsMEDLINE (PubMed), Embase, CENTRAL (Cochrane Central Register of Controlled Trials), Scopus, and ClinicalTrials databases were systematically searched for related articles up to August 2019. The primary outcomes included postoperative complications (overall postoperative complication, incision-related complication, anastomotic fistula, and severe complication) and pathologic results (lymph nodes harvested, proximal resection margin, and distal resection edge). The statistical analysis was performed on STATA 12.0 software.

resultsTen studies comprising 1787 patients were used for meta-analysis. Compared with AISE-LAR, NOSE-LAR had more advantages in terms of overall postoperative complication (odds ratio (OR) = 0.65 (95% CI, 0.46 to 0.90; P = 0.01)), incision-related complication (OR = 0.13 (95% CI, 0.05 to 0.35; P < 0.01)), distal resection edge (weighted mean difference (WMD) = 0.17 cm (95% CI, 0.02 to 0.33 cm; P = 0.02)), recovery of gastrointestinal function (WMD = - 0.38 day (95% CI, - 0.70 to - 0.06 day; P = 0.02 )), pain scores in postoperative day 1 (WMD = - 1.64 (95% CI, - 2.31 to - 0.98; P < 0.01)), additional analgesics usage (OR = 0.21 (95% CI, 0.11 to 0.40; P < 0.01)) and hospital stay (WMD = - 0.71 day (95% CI, - 1.10 to - 0.32 day; P < 0.01)), while the operation time of NOSE-LAR was prolonged (WMD = 7.4 min (95% CI, 0.17 to 14.64 min; P = 0.04)). The anastomotic fistula, severe complication, lymph nodes harvested, proximal resection margin, intraoperative blood loss, and long-term outcomes in NOSE-LAR were comparable with AISE-LAR.

conclusionsThe safety of NOSE-LAR was demonstrated, and it could be an alternative to conventional surgery in laparoscopic anterior resection for sigmoid and rectal tumors. However, further randomized and multi-center trials are required.

Indexed as

LaparoscopyNatural Orifice Endoscopic SurgeryRectal NeoplasmsColon, SigmoidHumansOperative TimePrognosisTreatment OutcomeLaparoscopic anterior resectionMeta-analysisNatural orifice specimen extractionNOSERectal tumorSigmoid tumor

Identifiers

PMID32814583
PMCPMC7439723
OpenAlexW3075557328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.